read more

first_img News | Proton Therapy | August 08, 2019 MD Anderson to Expand Proton Therapy Center The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a… read more News | Radiation Therapy | August 02, 2019 Varian Showcases Cancer Care Systems and Software at AAPM 2019 Varian showcased systems and software from its cancer care portfolio, including the Identify Guidance System, at the… read more Catalyst PT image courtesy of C-RAD News | Patient Positioning Radiation Therapy | August 15, 2019 Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton… read more News | August 12, 2014 MUSC Hollings Cancer Center Unveils New TrueBeam STx Installation TrueBeam STx expands radiation oncology services, offers patients shorter treatment time Related Content News | Radiation Therapy | August 16, 2019 Drug Accelerates Blood System’s Recovery After Radiation, Chemotherapy A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem… read more News | Proton Therapy | August 06, 2019 IBA Signs Contract to Install Proton Therapy Center in Kansas IBA (Ion Beam Applications S.A.) recently signed a contract and received the first payment for a Proteus One solution… read more News | Patient Positioning Radiation Therapy | August 07, 2019 Qfix kVue One Proton Couch Top Validated by Mevion Medical Systems Qfix and Mevion Medical Systems announced that a special version of the kVue One Proton couch top is now both validated… read more August 12, 2014 — New technology installed at the Medical University of South Carolina (MUSC) Hollings Cancer Center in Charleston offers patients a nonsurgical, specialized form of treatment that can be completed in five or fewer outpatient sessions, each lasting 20 minutes or less. The first patient will be treated on Aug. 13.An investment made in partnership with national radiosurgery provider Alliance Oncology, TrueBeam STx by Varian Medical Systems is an advanced cancer treatment system that treats patients with stereotactic radiosurgery (SRS), a noninvasive method of treating tumors with high-dose radiation precisely matched to the size and shape of the tumor. This pinpoint accuracy minimizes radiation exposure to healthy tissue and allows physicians to customize treatment for different types of cancer, including more complex cases.“TrueBeam STx will allow us to enhance the patient experience by significantly reducing treatment time to five or fewer visits, which will allow patients who receive the treatment to spend more time with their families and to focus on other activities,” said Joseph Jenrette III, M.D., chairman of the department of radiation oncology at MUSC. “TrueBeam STx can give hope to patients with inoperable or surgically complex tumors, as well as those seeking an alternative to surgery or conventional radiation therapy.”TrueBeam STx is capable of treating cancerous and noncancerous tumors in the body, including the lung, brain, prostate, spine, liver, pancreas, kidney, bone and eye. It can also treat certain blood vessel abnormalities, as well as trigeminal neuralgia, a neuropathic disorder that causes intense facial pain.Treatments with TrueBeam STx are available at the MUSC Health main campus in downtown Charleston and will be available in Mount Pleasant in early 2015. An open house will be held at the main hospital on Thursday, Aug. 14, from 4-6 p.m. and will include demonstrations of the new technology.For more information: www.muschealth.org/radonc FacebookTwitterLinkedInPrint分享 News | Radiation Oncology | July 31, 2019 Laura Dawson, M.D., FASTRO, Chosen as ASTRO President-elect The members of the American Society for Radiation Oncology (ASTRO) elected four new officers to ASTRO’s Board of… read more The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec. Feature | August 05, 2019 | Dave Fornell, Editor Most Popular Radiology and Radiotherapy Topics in July 2019 August 5, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine website fr read more News | Brachytherapy Systems | August 14, 2019 Efficacy of Isoray’s Cesium Blu Showcased in Recent Studies August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica read more News | Radiation Therapy | August 15, 2019 First Patient Enrolled in World’s Largest Brain Cancer Clinical Trial Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive… read more The top piece of content in July was a video interview explaining how Princess Margaret Cancer Center is using machine learning to create automated treatment plans. This was a hot topic at the American Association of Physicists in Medicine (AAPM) 2019 meeting in July.  Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communicationslast_img

Leave a Reply